Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870 [E-mail Us]

DOCKETS ENTERED on October 1, 2001

TABLE OF CONTENTS

Hyper links are part of the Docket  title - not all dockets/documents are linked

NOTE:  Documents received by the Dockets Management Branch "MAY" be posted on the Internet.

PLEASE DO NOT  include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence.

[FDA DOCKETS PAGE] [FDA HOME PAGE]  [ ITEM CODES ]

 
74P-0001 Vinyl Chloride as ingredient Drug/Cosmetic Aerosol Products *
75N-183H Health-Care Antiseptic Drug Products for OTC Human Use *
98N-0359 Program priorities/Center for Food Safety & Applied Nutritin *
98P-0151 Introduction Of Downed Cattle Into The Food Supply *
98P-0610 Convert Allegra/Allegra-D,Claritin/Claritin-D,Zyrtec to OTC *
00D-1598 Voluntary Labeling for Bioengineered Foods *
00P-1210 Restrict Sale of Coal Tar-Containing Products *
01P-0075 Switch Status of Emergency Contraceptives from Rx to OTC *
01P-0396 Request that FDA ban the production and sale of all ephedra *

74P-0001 Vinyl Chloride as ingredient Drug/Cosmetic Aerosol Products

BKG 1 BACKGROUND Vol#: 1

C 1 City of Syracuse,Department of Law Vol#: 1

C 2 American Academy of Pediatrics Vol#: 1

C 3 Continental Oil Company Vol#: 1

CP 1 Health Research Group Vol#: 1

NPR 1 Vol#: 1

75N-183H Health-Care Antiseptic Drug Products for OTC Human Use

C 60 Lonza, Inc. Vol#: 60

RPT 5 Steris Corporation Vol#: 111

76N-052G OTC general comments & combinations

NFR 3 Vol#: 35

97D-0318 Revised Precautionary Measure to Reduce Transmission of CJD

NEC 1 Vol#: 1

97N-0511 Procedures the safe and sanitary processing/importing juice

C 769 National Food Processors Assn Vol#: 31

98N-0359 Program priorities/Center for Food Safety & Applied Nutritin

C 72 Biotechnology Industry Organization Vol#: 6

98P-0151 Introduction Of Downed Cattle Into The Food Supply

C 5224 Ms. Natalie Kriegler Vol#: 180

C 5225 Benjamin Bristell Vol#: 180

C 5226 Crystal Nilsson Vol#: 180

C 5227 Hallie Hendricks Vol#: 180

C 5228 Jane Hamilton Vol#: 180

EMC 2312 Gary Farr Vol#: 180

EMC 2313 Jan Vol#: 180

EMC 2314 Monica Gonzales Vol#: 180

EMC 2315 Keith Landon Vol#: 180

EMC 2316 Meredith Erickson Vol#: 180

EMC 2317 Susan Siminow Vol#: 180

EMC 2318 Eleanor Thomas Vol#: 180

EMC 2319 Billie B. Nixon Vol#: 180

98P-0610 Convert Allegra/Allegra-D,Claritin/Claritin-D,Zyrtec to OTC

C 44 Directors Guild of America Vol#: 5

00D-1598 Voluntary Labeling for Bioengineered Foods

C 9490 Form Letter Count 259 Vol#: 504

C 9491 Form Letter Count 39 Vol#: 505

C 9492 Form Letter Count 40 Vol#: 506

C 9493 Form Letter Count 7,852 signatures Vol#: 507

C 9494 Janie Nobles Vol#: 476

C 9495 Mary Hartup Vol#: 476

C 9496 Mary Bateman Vol#: 476

C 9497 No signature Vol#: 476

C 9498 Belynda Justice Vol#: 476

00P-1210 Restrict Sale of Coal Tar-Containing Products

LET 3 HFC-1 to Bell, Boyd & Lloyd, L.L.C. Vol#: 1

01E-0098 TNKase, Patent Extension Application No.5,385,732

N 1 Vol#: 1

01M-0439 PMA Deflux Injectable Gel, P000029

AAV 1 Q-Med AB Vol#: 1

01N-0398 Format and Content Requirements for OTC Drug Product Labelin

N 1 Vol#: 1

01N-0399 Rapid Response Surveys

N 1 Vol#: 1

01N-0400 Safety & Effectiveness of New Drug & Biological Products in

N 1 Vol#: 1

01P-0075 Switch Status of Emergency Contraceptives from Rx to OTC

C 234 Mary Lou Jasken Vol#: 10

01P-0245 Determination that Disulfiram was withdrawn for reasons othe

N 1 Vol#: 1

01P-0396 Request that FDA ban the production and sale of all ephedra

EMC 1 Nik Willmore, PhD Vol#: 1

EMC 2 Denise Nance Vol#: 1

EMC 3 Ben Munguia Vol#: 1

01V-0448 Laser Light Show

ACK 1 HFA-305 Vol#: 1

VAR 1 Powerline Productions Vol#: 1